资讯
Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States ...
Blepharitis is classified into three types that include anterior, posterior, and mixed blepharitis. In anterior blepharitis, the eyelid skin, base, and follicles of the eyelashes are affected.
Viatris's phase 3 trial for pimecrolimus 0.3% in blepharitis failed to meet its primary endpoint of debris resolution after ...
Blepharitis (blef-uh-RYE-tis) is inflammation of the eyelids. Blepharitis usually involves the part of the eyelid where the eyelashes grow and affects both eyelids. Blepharitis commonly occurs ...
Since blepharitis is often caused by the collection of bacteria, oil or mites, good eyelid hygiene is a smart first step. It “can help remove debris and reduce bacterial buildup,” Dr. Kopelman ...
Blepharitis (blef-uh-RYE-tis) is inflammation of the eyelids. Blepharitis usually involves the part of the eyelid where the eyelashes grow and affects both eyelids. Blepharitis commonly occurs ...
Blepharitis is an inflammatory condition of the eyelid margins and likely to be the most under-diagnosed, undertreated, and underappreciated eye disease worldwide. 1 Traditionally, clinicians ...
Blepharitis is normally characterised by lid crusting, redness, misdirected lashes and styes. However, it is non-contagious and usually affects the lower eyelid and eyelashes.
11 天
Clinical Trials Arena on MSNViatris’ blepharitis ointment fails Phase III trialViatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...
Viatris reported that its MR-139 ophthalmic ointment failed to meet its primary endpoint in a Phase III blepharitis trial, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果